Literature DB >> 3058969

Prolonged inflammatory reactions induced by artificial ceramics in the rat air pouch model.

M Nagase1, D G Baker, H R Schumacher.   

Abstract

The male Sprague-Dawley rat subcutaneous air pouch was used to study the inflammatory potential of artificial ceramics that are used in joint replacement surgery. Local leukocyte influx, proteinase, prostaglandin E2 (PGE2) and tumor necrosis factor (TNF) levels were measured after injection of hydroxyapatite type I ceramic (HAP), tricalcium phosphate ceramic (TCP) and apatite-wollastonite glass ceramic (GC) into the pouch. Synthetic monosodium urate crystals (MSU) were used as positive controls and normal saline (NS) was a negative control. The response was monitored over 168 h by irrigating the pouch with 5 ml of NS and withdrawing 4 ml. MSU produced the greatest response in leukocyte counts, proteinase and PGE2, whereas HAP, TCP and GC elicited less response. The peak response with HAP, TCP and GC often appeared later than with MSU. TNF activity was significantly detected only after ceramics and not after MSU. The chronic and relatively prolonged reaction to some ceramics suggests that an inflammatory reaction may be seen after human implantation of these ceramics. The increased levels of TNF and production of PGE2, which is one substance proposed to contribute to bone lysis associated with loosening, are of special interest.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3058969

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  13 in total

Review 1.  The role of crystals in articular tissue degeneration.

Authors:  H S Cheung
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

2.  Local immune inflammatory response to infected total hip and knee replacements.

Authors:  D Nordström; S Santavirta; I Antti-Poika; Y T Konttinen
Journal:  Arch Orthop Trauma Surg       Date:  1994       Impact factor: 3.067

3.  Remodeling of large bone defects in the treatment of space-occupying lesions. Curettage without bone graft for treating benign bone tumors.

Authors:  M Chigira; H Watanabe; S Arita; K Noda; T Shimizu; T Shinozaki; M Nagase
Journal:  Arch Orthop Trauma Surg       Date:  1992       Impact factor: 3.067

Review 4.  Calcium Orthophosphate-Based Bioceramics.

Authors:  Sergey V Dorozhkin
Journal:  Materials (Basel)       Date:  2013-09-06       Impact factor: 3.623

5.  Anti-inflammatory activity of hyperimmune plasma in a lipopolysaccharide-mediated rat air pouch model of inflammation.

Authors:  Bryan E Essien; Michael Kotiw
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

6.  Arthrotomy-based preclinical models of particle-induced osteolysis: A systematic review.

Authors:  Meghan M Moran; Brittany M Wilson; Ryan D Ross; Amarjit S Virdi; Dale Rick Sumner
Journal:  J Orthop Res       Date:  2017-06-28       Impact factor: 3.494

7.  Effects of cytokine gene therapy on particulate-induced inflammation in the murine air pouch.

Authors:  S Sud; S Y Yang; C H Evans; P D Robbins; P H Wooley
Journal:  Inflammation       Date:  2001-12       Impact factor: 4.092

8.  Hydroxyapatite particles are capable of inducing osteoclast formation.

Authors:  A Sabokbar; R Pandey; J Díaz; J M Quinn; D W Murray; N A Athanasou
Journal:  J Mater Sci Mater Med       Date:  2001-08       Impact factor: 3.896

9.  Reduction of urate crystal-induced inflammation by root extracts from traditional oriental medicinal plants: elevation of prostaglandin D2 levels.

Authors:  Sung Mun Jung; H Ralph Schumacher; Hocheol Kim; Miyeon Kim; Seoung Hoon Lee; Frank Pessler
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

10.  Identification of novel monosodium urate crystal regulated mRNAs by transcript profiling of dissected murine air pouch membranes.

Authors:  Frank Pessler; Christian T Mayer; Sung Mun Jung; Ed M Behrens; Lie Dai; Joseph P Menetski; H Ralph Schumacher
Journal:  Arthritis Res Ther       Date:  2008-06-03       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.